These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22765047)

  • 1. Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis.
    Stavropoulos-Kalinoglou A; Metsios GS; Panoulas VF; Nightingale P; Koutedakis Y; Kitas GD
    Arthritis Res Ther; 2012 Jul; 14(4):R160. PubMed ID: 22765047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance.
    Stagakis I; Bertsias G; Karvounaris S; Kavousanaki M; Virla D; Raptopoulou A; Kardassis D; Boumpas DT; Sidiropoulos PI
    Arthritis Res Ther; 2012 Jun; 14(3):R141. PubMed ID: 22691241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis.
    Kiortsis DN; Mavridis AK; Vasakos S; Nikas SN; Drosos AA
    Ann Rheum Dis; 2005 May; 64(5):765-6. PubMed ID: 15458960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
    Burska AN; Sakthiswary R; Sattar N
    PLoS One; 2015; 10(6):e0128889. PubMed ID: 26110878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance in patients with rheumatoid arthritis: effect of anti-TNFalpha therapy.
    Rosenvinge A; Krogh-Madsen R; Baslund B; Pedersen BK
    Scand J Rheumatol; 2007; 36(2):91-6. PubMed ID: 17476613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms.
    Chung CP; Oeser A; Solus JF; Gebretsadik T; Shintani A; Avalos I; Sokka T; Raggi P; Pincus T; Stein CM
    Arthritis Rheum; 2008 Jul; 58(7):2105-12. PubMed ID: 18576352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-Sensiting Effects of Tumor Necrosis Factor Alpha Inhibitors in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
    Leporini C; Russo E; D Angelo S; Arturi F; Tripepi G; Peluso R; Grembiale RD; Olivieri I; De Sarro G; Ursini F
    Rev Recent Clin Trials; 2018; 13(3):184-191. PubMed ID: 29542420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients.
    Yokoyama H; Emoto M; Fujiwara S; Motoyama K; Morioka T; Komatsu M; Tahara H; Shoji T; Okuno Y; Nishizawa Y
    Diabetes Care; 2003 Aug; 26(8):2426-32. PubMed ID: 12882874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance is associated with increased concentrations of NT-proBNP in rheumatoid arthritis: IL-6 as a potential mediator.
    Bradham WS; Ormseth MJ; Oeser A; Solus JF; Gebretsadik T; Shintani A; Stein CM
    Inflammation; 2014 Jun; 37(3):801-8. PubMed ID: 24402421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor γ agonist effect on rheumatoid arthritis: a randomized controlled trial.
    Ormseth MJ; Oeser AM; Cunningham A; Bian A; Shintani A; Solus J; Tanner S; Stein CM
    Arthritis Res Ther; 2013; 15(5):R110. PubMed ID: 24020899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does TNF-alpha blockade play any role in cardiovascular risk among rheumatoid arthritis (RA) patients?
    Cuchacovich R; Espinoza LR
    Clin Rheumatol; 2009 Oct; 28(10):1217-20. PubMed ID: 19517156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity is the main determinant of insulin resistance more than the circulating pro-inflammatory cytokines levels in rheumatoid arthritis patients.
    Castillo-Hernandez J; Maldonado-Cervantes MI; Reyes JP; Patiño-Marin N; Maldonado-Cervantes E; Solorzano-Rodriguez C; de la Cruz Mendoza E; Alvarado-Sanchez B
    Rev Bras Reumatol Engl Ed; 2017; 57(4):320-329. PubMed ID: 28743359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical remission following treatment with tumour necrosis factor-alpha antagonists is not accompanied by changes in asymmetric dimethylarginine in patients with rheumatoid arthritis.
    Sandoo A; Dimitroulas T; Toms TE; Hodson J; Veldhuijzen van Zanten JJ; Smith JP; Kitas GD
    Clin Biochem; 2012 Nov; 45(16-17):1399-403. PubMed ID: 22820438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of anti-TNF treatment on body composition and insulin resistance in patients with rheumatoid arthritis.
    van den Oever IAM; Baniaamam M; Simsek S; Raterman HG; van Denderen JC; van Eijk IC; Peters MJL; van der Horst-Bruinsma IE; Smulders YM; Nurmohamed MT
    Rheumatol Int; 2021 Feb; 41(2):319-328. PubMed ID: 32776224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA study.
    Bissell LA; Hensor EM; Kozera L; Mackie SL; Burska AN; Nam JL; Keen H; Villeneuve E; Donica H; Buch MH; Conaghan PG; Andrews J; Emery P; Morgan AW
    Rheumatology (Oxford); 2016 Dec; 55(12):2181-2190. PubMed ID: 27638812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus risk in rheumatoid arthritis: reduced incidence with anti-tumor necrosis factor α therapy.
    Antohe JL; Bili A; Sartorius JA; Kirchner HL; Morris SJ; Dancea S; Wasko MC
    Arthritis Care Res (Hoboken); 2012 Feb; 64(2):215-21. PubMed ID: 21972198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid beneficial effect of the IL-6 receptor blockade on insulin resistance and insulin sensitivity in non-diabetic patients with rheumatoid arthritis.
    Castañeda S; Remuzgo-Martínez S; López-Mejías R; Genre F; Calvo-Alén J; Llorente I; Aurrecoechea E; Ortiz AM; Triguero A; Blanco R; Llorca J; González-Gay MA
    Clin Exp Rheumatol; 2019; 37(3):465-473. PubMed ID: 30418124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRP, but not TNF-α or IL-6, decreases after weight loss in patients with morbid obesity exposed to intensive weight reduction and balneological treatment.
    Rość D; Adamczyk P; Boinska J; Szafkowski R; Ponikowska I; Stankowska K; Góralczyk B; Ruszkowska-Ciastek B
    J Zhejiang Univ Sci B; 2015 May; 16(5):404-11. PubMed ID: 25990058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of 3-month changes in bone microstructure under anti-TNFα therapy in patients with rheumatoid arthritis using high-resolution peripheral quantitative computed tomography (HR-pQCT).
    Shimizu T; Choi HJ; Heilmeier U; Tanaka M; Burghardt AJ; Gong J; Chanchek N; Link TM; Graf J; Imboden JB; Li X
    Arthritis Res Ther; 2017 Oct; 19(1):222. PubMed ID: 28978352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis.
    Gonzalez-Gay MA; De Matias JM; Gonzalez-Juanatey C; Garcia-Porrua C; Sanchez-Andrade A; Martin J; Llorca J
    Clin Exp Rheumatol; 2006; 24(1):83-6. PubMed ID: 16539824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.